Brought to you by 
DexCom nets $50.6mm with its IPO
05 May 2005
Executive Summary
Medical device company DexCom (glucose monitors) has netted $50.6mm with its initial public offering of 4.7mm common shares. The company priced the shares at $12 each, the low end of its original range, which was $12-14 when it filed in February (just a month after grossing $22.5mm with its Series D round).
Deal Industry
- Medical Devices
-
Medical Devices
- Diagnostic Equipment & Supplies
- Implantable Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Biosensors
- Glucose Testing
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
DexCom nets $50.6mm with its IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice